OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

W. Dodick, David; C. Turkel, Catherine; E. DeGryse, Ronald; K. Aurora, Sheena; D. Silberstein, Stephen; B. Lipton, Richard; Diener, Hans‐Christoph; F. Brin, Mitchell

doi:10.1111/j.1526-4610.2010.01678.x

Public

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

Published in Headache The Journal of Head and Face Pain • May 7, 2010

Authors:

David W. Dodick

Catherine C. Turkel

Ronald E. DeGryse

Abstract

OBJECTIVE: To assess the efficacy, safety, and tolerability of onabotulinumtoxinA (BOTOX) as headache prophylaxis in adults with chronic migraine. BACKGROUND: Chronic migraine is a prevalent, disabling, and undertreated neurological disorder. Few preventive treatments have been investigated and none...

Subject

Tolerability

Medicine

Migraine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!